Home > Newsletters > FDAnews Device Daily Bulletin > Industry Groups Call Out CMC Over New EU Labeling Requirement
FDAnews Device Daily Bulletin
June 29, 2012 | Vol. 9 No. 128
Industry Groups Call Out CMC Over New EU Labeling Requirement
Implementing a new labeling requirement by the EU’s Central Management Committee (CMC) on Medical Devices will raise devicemakers’ costs without any benefit to patient safety, industry association Eucomed says. “Decision No. 3” requires medical devicemakers to put their complete street address on both the device label and instructions for use. The new requirement means companies can no longer list the addresses of post office boxes, sales offices or customer centers.
International Medical Device Regulatory Monitor
Devicemakers Must ‘Act Now’ on Objections to EU Device RegulationsRapporteur Seeks Stricter Controls Over Clinical IVD Trials, Genetic TestingIVD Makers Face ‘Quantum Leap’ in Requirements Under Proposed EU RegRapporteur for IVD Regulation Seeks Stricter Controls Over Clinical Trials, Genetic Testing
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.